Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RAAJ MEDISAFE Share Price   (MNSG)



Here is the latest stock price and chart of RAAJ MEDISAFE. For more details, see the RAAJ MEDISAFE company fact sheet and quarterly results.

Revealing Soon: A Potential Huge Investing Opportunity for Investors

REFRESH
Live BSE Quotes May 22, 2024 (Close)
Price (Rs)71.80 Open (Rs) 72.50 High (Rs) 72.50 Low (Rs) 71.80
% Change-1.09 Volume 700 Value (Rs) 50,610 52-Week H/L 76.11 / 31.20
Live NSE Quotes
Not listed
Change
1 Day
-1.09%
Valuation
EPS (Rs)* 2.42 P/E Ratio (x) 29.70 Market Cap (Rs m) 948.66 P/BV (x) 4.70 Dividend Yield (%) 0.00
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

As of March 2024, company promoters held 73.45% stake in , with no shares having been pledged. To know more, check out the latest shareholding pattern of .



FAQs on RAAJ MEDISAFE

What is the RAAJ MEDISAFE share price today?

The last traded price of RAAJ MEDISAFE was Rs 71.8 on the BSE, down 1.1% over the previous close.

What is the market cap of RAAJ MEDISAFE?

The current market capitalisation of RAAJ MEDISAFE stands at Rs 949 m.

What is the Earnings per share (EPS) of RAAJ MEDISAFE?

RAAJ MEDISAFE had an EPS of Rs 2.4 in the latest financial year.

What is the PE Ratio and PB Ratio of RAAJ MEDISAFE?

At the current price of Rs 71.8, RAAJ MEDISAFE trades at a PE ratio of 29.70 while its PB ratio stands at 4.70.


Today's Market

Sensex Today Trades Higher | Smallcap Stocks Shine | Gland Pharma Rallies 8% Sensex Today Trades Higher | Smallcap Stocks Shine | Gland Pharma Rallies 8%(10:30 am)

Asian share benchmarks fell on Thursday as markets digested the implications of policymakers in major economies preferring to take patient approach to monetary easing amid sticky inflation.